Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001140361-23-047695
Filing Date
2023-10-11
Accepted
2023-10-11 08:56:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A ny20011256x1_sc14d9a.htm SC 14D9/A 31819
  Complete submission text file 0001140361-23-047695.txt   33638
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88971 | Film No.: 231319488
SIC: 2834 Pharmaceutical Preparations